Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler.

ABSTRACT:

Introduction

Preliminary clinical studies on medical cannabis (MC) treatment using the Syqe Inhaler showed short-term effectiveness and safety at very low and precise doses of MC.

Objectives

Here, we retrospectively analyzed "real-life" long-term data collected in real time on the potential effectiveness and safety of MC administered with this device.

Methods

Patients were monitored by Syqe's patient support program. (-)-Δ⁹-trans-Tetrahydrocannabinol (Δ⁹-THC) served as a dosage marker for full-spectrum MC. Pain intensity was evaluated using a numeric pain scale (NPS) from baseline to 120 days after treatment initiation. The change in quality of life (QoL) from baseline was evaluated. Adverse events (AEs) were followed up continuously for 15 month

SUBMITTER: Aviram J 

PROVIDER: S-EPMC9116950 | biostudies-literature | 2022 May-Jun

REPOSITORIES: biostudies-literature